The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia.
Affiliation
Médecins Sans Frontières, Aral Sea Area Programme, Uzbekistan and Turkmenistan Tashkent, Uzbekistan. h.cox2@pgrad.unimelb.edu.auIssue Date
2005
Metadata
Show full item recordJournal
Respiratory ResearchAbstract
BACKGROUND: After the collapse of the Soviet Union, dramatically increasing rates of tuberculosis and multidrug-resistant tuberculosis (MDR-TB) have been reported from several countries. This development has been mainly attributed to the widespread breakdown of TB control systems and declining socio-economic status. However, recent studies have raised concern that the Beijing genotype of Mycobacterium tuberculosis might be contributing to the epidemic through its widespread presence and potentially enhanced ability to acquire resistance. METHODS: A total of 397 M. tuberculosis strains from a cross sectional survey performed in the Aral Sea region in Uzbekistan and Turkmenistan have been analysed by drug susceptibility testing, IS6110 fingerprinting, and spoligotyping. RESULTS: Fifteen isolates showed mixed banding patterns indicating simultaneous infection with 2 strains. Among the remaining 382 strains, 152 (40%) were grouped in 42 clusters with identical fingerprint and spoligotype patterns. Overall, 50% of all isolates were Beijing genotype, with 55% of these strains appearing in clusters compared to 25% of non-Beijing strains. The percentage of Beijing strains increased with increasing drug resistance among both new and previously treated patients; 38% of fully-susceptible isolates were Beijing genotype, while 75% of MDR-TB strains were of the Beijing type. CONCLUSION: The Beijing genotype is a major cause of tuberculosis in this region, it is strongly associated with drug resistance, independent of previous tuberculosis treatment and may be strongly contributing to the transmission of MDR-TB. Further investigation around the consequences of Beijing genotype infection for both tuberculosis transmission and outcomes of standard short course chemotherapy are urgently needed.PubMed ID
16277659Language
enISSN
1465-993Xae974a485f413a2113503eed53cd6c53
10.1186/1465-9921-6-134
Scopus Count
Collections
Related articles
- Mycobacterium tuberculosis Beijing lineage favors the spread of multidrug-resistant tuberculosis in the Republic of Georgia.
- Authors: Niemann S, Diel R, Khechinashvili G, Gegia M, Mdivani N, Tang YW
- Issue date: 2010 Oct
- Drug resistant Mycobacterium tuberculosis of the Beijing genotype does not spread in Sweden.
- Authors: Ghebremichael S, Groenheit R, Pennhag A, Koivula T, Andersson E, Bruchfeld J, Hoffner S, Romanus V, Källenius G
- Issue date: 2010 May 28
- Spoligotype-based comparative population structure analysis of multidrug-resistant and isoniazid-monoresistant Mycobacterium tuberculosis complex clinical isolates in Poland.
- Authors: Jagielski T, Augustynowicz-Kopec E, Zozio T, Rastogi N, Zwolska Z
- Issue date: 2010 Nov
- The Beijing genotype is a major cause of drug-resistant tuberculosis in Kazakhstan.
- Authors: Kubica T, Agzamova R, Wright A, Aziz MA, Rakishev G, Bismilda V, Richter E, Rüsch-Gerdes S, Niemann S
- Issue date: 2005 Jun
- [Population-based molecular epidemiologic study of rifampicin-resistant tuberculosis in rural area of eastern China].
- Authors: Wang JJ, Hu Y, Jiang WL, Wang WB, Xu B
- Issue date: 2009 Nov